Back
Moleculin Biotech Stock Price Chart
Sponsored
MBRX
Sponsored
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More
Sell
19
MBRX
Moleculin Biotech
Last Price:
2.72
Seasonality Move:
-11.13%
7 Day Trial
ALL ACCESS PASS
$
7
Do you own any of the "SELL" rated stocks on this list?
Go here now to get free instant access to all 20 stocks to sell.- The current trend is relatively stagnant and MBRX is experiencing selling pressure, which indicates risk of future bearish movement.
Moleculin Biotech Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.48 | Sell |
20-day SMA: | 2.46 | Sell |
50-day SMA: | 2.67 | Sell |
200-day SMA: | 5.63 | Sell |
8-day EMA: | 2.48 | Sell |
20-day EMA: | 2.48 | Sell |
50-day EMA: | 2.77 | Sell |
200-day EMA: | 5.14 | Sell |
Moleculin Biotech Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 46.67 | Sell |
Chaikin Money Flow: | -18520 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.37 - 2.55) | Sell |
Bollinger Bands (100): | (2.49 - 4.47) | Sell |
Moleculin Biotech Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Moleculin Biotech Stock
Is Moleculin Biotech Stock a Buy?
- Moleculin Biotech share price is 2.44 while MBRX 8-day simple moving average is 2.48, which is a Sell signal.
- The stock price of MBRX is 2.44 while Moleculin Biotech 20-day SMA is 2.46, which makes it a Sell.
- Moleculin Biotech 50-day simple moving average is 2.67 while MBRX share price is 2.44, making it a Sell technically.
- MBRX stock price is 2.44 and Moleculin Biotech 200-day simple moving average is 5.63, creating a Sell signal.
MBRX Technical Analysis vs Fundamental Analysis
Sell
19
Moleculin Biotech (MBRX)
is a Sell
Is Moleculin Biotech a Buy or a Sell?
-
Moleculin Biotech stock is rated a Sell
The current Moleculin Biotech [MBRX] share price is $2.44. The Score for MBRX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Moleculin Biotech Stock Info
Market Cap:
6.94M
Price in USD:
2.44
Share Volume:
26.49K
Moleculin Biotech 52-Week Range
52-Week High:
15.75
52-Week Low:
2.12
Sell
19
Moleculin Biotech (MBRX)
is a Sell
Moleculin Biotech Share Price Forecast
-
What is the Moleculin Biotech stock price today?
The Moleculin Biotech stock price is 2.44 USD today. -
Will MBRX stock go up or go down?
Moleculin Biotech> share price is forecast to RISE/FALL based on technical indicators -
Is Moleculin Biotech overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Moleculin Biotech is overvalued.
Is Moleculin Biotech Stock a Buy?
- Moleculin Biotech share price is 2.44 while MBRX 8-day exponential moving average is 2.48, which is a Sell signal.
- The stock price of MBRX is 2.44 while Moleculin Biotech 20-day EMA is 2.48, which makes it a Sell.
- Moleculin Biotech 50-day exponential moving average is 2.77 while MBRX share price is 2.44, making it a Sell technically.
- MBRX stock price is 2.44 and Moleculin Biotech 200-day simple moving average is 5.14, creating a Sell signal.
Fundamental Analysis of Moleculin Biotech
Is Moleculin Biotech a good investment?
- Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.
Technical Analysis of Moleculin Biotech
Should I short Moleculin Biotech stock?
- MBRX Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Moleculin Biotech is a Sell
- Moleculin Biotech Relative Strength Index (RSI) is 46.67, which suggest Moleculin Biotech is oversold
- The Bollinger Bands (25) for Moleculin Biotech is (2.37 - 2.55), which suggest Moleculin Biotech is a Sell
- The Bollinger Bands (100) for Moleculin Biotech is (2.49 - 4.47), which suggest Moleculin Biotech is a Sell
* Moleculin Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.